Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Vermont Medicare Details, Address, Contact
7 Thoracic Surgery (Cardiothoracic Vascular Surgery) doctors found. Showing 1 - 7
 Stephen Marcus, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher 4, Burlington, VT 05401 Phone: 802-847-4044 Fax: 802-847-8158 |
Mr. Stephen Colmenero, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4152 Fax: 802-847-8158 |
 Fuyuki Hirashima, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2566 |
Dr. Monica L Mcdonald, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 |
Dr. Frank Paul Ittleman, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher 4, Burlington, VT 05401 Phone: 802-847-4152 Fax: 802-847-8158 |
Dr. Mitchell Craig Norotsky, DR Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4152 Fax: 802-847-8158 |
Claude Deschamps, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Executive Office, Patrick 318, Burlington, VT 05401 Phone: 802-847-2779 Fax: 802-847-5677 |
News Archive
Researchers use bioelectrical impedance analysis ratios to assess Lymphedema in breast cancer patients
Viewed as one of the most feared outcomes of breast cancer treatment, doctors struggle detecting and diagnosing breast-cancer related Lymphedema-a condition affecting the lymphatic system and causing psychosocial distress and physical challenges for patients.
Emergent BioSolutions completes sales, deliveries of BioThrax to allied international governments
Emergent BioSolutions Inc. announced today that it has completed separate international sales and deliveries of BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations. The company's international sales efforts have resulted in these sales of an undisclosed number of BioThrax doses for aggregate revenue of approximately $2.3 million in the second quarter.
Novel biomarker-development pipeline approach for human diseases
Researchers at Fred Hutchinson Cancer Research Center have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans.
Affitech, Cancer Research Technology sign deal to advance therapeutic antibodies
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
› Verified 2 days ago